Evidence map›Paper›PMID 33946599›Full record

ArticleMolecules (Basel, Switzerland)2021

Preclinical Assessment Addressing Intravenous Administration of a [

Vusani Mandiwana, Lonji Kalombo, Rose Hayeshi, Jan Rijn Zeevaart, Thomas Ebenhan

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Biodistribution ofInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vusani MandiwanaCentre for Nanostructures and Advanced Materials CeNAM, Chemical Cluster, Advanced Functional Materials, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
Lonji KalomboCentre for Nanostructures and Advanced Materials CeNAM, Chemical Cluster, Advanced Functional Materials, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
Rose HayeshiDepartment of Science and Technology, Preclinical Drug Development Platform, North West University, Potchefstroom 2520, South Africa.
Jan Rijn ZeevaartDepartment of Science and Technology, Preclinical Drug Development Platform, North West University, Potchefstroom 2520, South Africa.ORCID 0000-0003-0794-3012
Thomas EbenhanDepartment of Science and Technology, Preclinical Drug Development Platform, North West University, Potchefstroom 2520, South Africa.ORCID 0000-0002-2038-7324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been herein presented that a microemulsion, known to be an effective and safe drug delivery system following intravenous administration, can be loaded with traces of [

Indexed as

EmulsionsRadiopharmaceuticalsAdministration, IntravenousAnimalsBiomarkersChemical PhenomenaDipeptidesEdetic AcidGallium IsotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingMaleMiceOligopeptidesPositron-Emission TomographyPositron Emission Tomography Computed TomographyBiomarkersDipeptidesEdetic AcidEmulsionsgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingOligopeptidesProstate-Specific AntigenPSMA-617RadiopharmaceuticalsZinc-68Zinc Isotopes68Ga[68Ga]Ga-PSMA-617-MEbiodistributionin vivomicroemulsionmicroPET/CTprostate cancerPSMA-617toxicity

Identifiers

PMID33946599
PMCPMC8124668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.